Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06556888

Observatory of Immunological Thrombopenic Purpura in the Brest Region

Database of patients with ITP, diagnosed, treated and followed in the Brest University Hospital.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Immune Thrombocytopenia Autoimmune Diseases Blood Coagulation Disorders Blood Platelet Disorders Cytopenia Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhage Hemorrhagic Disorders Immune System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Purpura Purpura, Thrombocytopenic Purpura, Thrombocytopenic, Idiopathic Signs and Symptoms Skin Manifestations Thrombocytopenia Thrombotic Microangiopathies

Sex eligibility

All sexes

Study type

Observational

Primary location

Hematology Department - Institute of Oncology and Hematology, University Hospital of Brest

Brest, Brittany Region, 29609, France

Location status: Recruiting

Location contact

Jean-Christophe Ianotto, MD, PhD

SUB_INVESTIGATOR

Veronique Kouassi

CONTACT

[email protected]

33298223333

About this study

Creation of a global clinical and biological database for all patients diagnosed, treated and followed for ITP in the University Hospital of Brest.

UHB is the regional reference center (competence center) on hemorrhagic diseases.

Dr Pan-Petesch, who is responsible of the local competence center, is affiliated to the national sector of auto-immune cytopenias CERECAI-MARIH).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with ITP agree to participate

Exclusion criteria

  • Other thrombocythopenia other than ITP
  • Patients Under guardianship
  • Patients without national social security

Treatment and study plan

Primary outcomes

  1. Description chronicity

    Time frame: 1 year

    Identification/description of risk factors of chronicity

  2. Description treatment responses

    Time frame: 1 year

    Identification/ description of risk factors of bad responses

Study contacts

Contact information is provided by the study sponsor or research team.

Brigitte Pan-Petesch, MD

CONTACT

[email protected]

33298223650

Veronique Kouassi

CONTACT

[email protected]

33298223333

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Observatory of Immunological Thrombopenic Purpura in the Brest Region: Descriptive and Comparative Cross-sectional Study

Acronym: OPTIMIST

Important dates

Study start
2019
Primary completion
2020
Study completion
2039
First posted
Aug 16, 2024
Registry last updated
Aug 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.